Thomas Odeny, MD, MPH, PhD
Global problems, like cancer, require global solutions.
Every year, millions of people around the world are diagnosed with cancer.
Molly Hones and Dr. Mark Lewis
Read the Full Transcript
Dr. Mark Lewis:
Marina Baretti, MD
Cancer research can be an excruciatingly long game.
Meet Molly: Relentless Resilience in the Face of Rare Cancer
Molly Hones had recently received her second rare cancer diagnosis in as many years—a rare liver cancer called fibrolamellar carcinoma (FLC). This time, it had spread to her lungs, elevating her diagnosis to stage 4.
Understanding Rare Cancers: What are they and why do we need to fund research for them?
While a single rare cancer might affect a small number of patients, rare cancers—as a whole—actually make up about 1 out of every 4 new cancer diagnoses and an estimated 30 percent of all cancer deaths every year.1 Here’s what you need to know about rare cancers and how you can help c
Dr. Yelena Janjigian and Dr. Mark Lewis
Read the Full Transcript
Dr. Mark Lewis:
John Paul Shen, MD
Of the approximately 78 organs in the human body, there are a handful that scientists have ultimately deemed unnecessary for survival. Of these, few are more problematic—or confounding—than the appendix.
Conquer Cancer®, the ASCO Foundation, Announces 2025 Quality Care Symposium Merit Awards Recipients
ALEXANDRIA, Va. — Conquer Cancer®, the ASCO Foundation, is pleased to announce the recipients of its 2025 Quality Care Symposium Merit Awards.
7 Common Grantwriting Mistakes—and How to Avoid Them
With cancer research funding facing critical shortfalls, the competition for grants gets tougher every day.
Empowering Early-Career Oncologists to Deliver Tomorrow's Cures: A Q&A with Dr. Tim Ohlsen
These are challenging times for early-career oncology researchers and—by extension—the patients and families who need the treatments and cures those researchers dedicate their careers to pursuing.